老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Silence Therapeutics Plc

13.02
-0.2900-2.18%
盤後：13.020.00000.00%19:30 EDT
成交量：68.59萬
成交額：898.37萬
市值：7.84億
市盈率：-10.26
高：13.42
開：13.32
低：12.88
收：13.31
52周最高：17.58
52周最低：4.19
股本：6,020.96萬
流通股本：4,822.70萬
量比：0.89
換手率：1.42%
股息：- -
股息率：- -
每股收益(TTM):-1.2693
每股收益(LYR):-1.8761
淨資產收益率：-90.41%
總資產收益率：-29.65%
市淨率：20.38
市盈率(LYR):-6.94

資料載入中...

總覽公司新聞公告
2022/02/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/29

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/11

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/11

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/03/09

招股説明書

F-1 - Registration statement for certain foreign private issuers
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/26

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/08/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/20

招股説明書

F-1 - Registration statement for certain foreign private issuers
2017/12/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2017/12/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2017/01/13

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership